Cargando…

Alteplase/epoprostenol: Lack of efficacy: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853886/ http://dx.doi.org/10.1007/s40278-022-10142-7

Ejemplares similares

Alteplase/enoxaparin-sodium: Lack of efficacy: case report
Publicado: (2021)

Epoprostenol/hydroxychloroquine/tocilizumab: Acute large bowel perforation, off-label use and lack of efficacy: case report
Publicado: (2020)

Epoprostenol: Exacerbation of thrombocytopenia : case report
Publicado: (2021)

Alteplase/heparin/low-molecular-weight-heparins: Lack of efficacy, femoral haemorrhage and jugular haemorrhage: 5 case reports
Publicado: (2020)

Stress Cardiomyopathy Precipitated by Withdrawal of Epoprostenol
por: Gionfriddo, William J., et al.
Publicado: (2020)

Alteplase: Various toxicities: 4 case reports
Publicado: (2022)

Alteplase: Fatal intracranial hemorrhage: case report
Publicado: (2021)

Epoprostenol‐associated ascites in pulmonary arterial hypertension
por: Schoenberg, Noah C., et al.
Publicado: (2022)

Transitioning intravenous epoprostenol to oral selexipag in idiopathic pulmonary arterial hypertension: a case report
por: Alexandre, André, et al.
Publicado: (2023)

Case report: Stepwise transition from subcutaneous treprostinil to epoprostenol in high-risk pulmonary arterial hypertension
por: Mori, Ana Laura, et al.
Publicado: (2021)

Successful use of inhaled epoprostenol as rescue therapy for pediatric ARDS
por: Urich, Alissa, et al.
Publicado: (2020)

Goiter in a Patient with Pulmonary Arterial Hypertension Treated with Epoprostenol
por: Abughazaleh, Shaadi, et al.
Publicado: (2020)

Epoprostenol: Flushing or Erythroderma?
por: Martínez-Martínez, María Luisa, et al.
Publicado: (2013)

Reversible Cardiac Hypertrophy in Pulmonary Arterial Hypertension Treated With High-Dose Epoprostenol
por: Izumi, Keiichi, et al.
Publicado: (2022)

Occult catheter rupture causing episodic symptoms in a patient treated with epoprostenol
por: LeVarge, Barbara L., et al.
Publicado: (2017)

Epoprostenol Exposure During Pregnancy
por: Naoum, Emily E., et al.
Publicado: (2023)

Heparin: Lack of efficacy: case report
Publicado: (2022)

Heparin: Lack of efficacy : case report
Publicado: (2022)

Heparin: Lack of efficacy: case report
Publicado: (2022)

Methotrexate: Lack of efficacy: case report
Publicado: (2022)

Heparin: Lack of efficacy: case report
Publicado: (2022)

Acenocoumarol: Lack of efficacy: case report
Publicado: (2022)

Anidulafungin: Lack of efficacy: case report
Publicado: (2022)

Anticoagulants: Lack of efficacy: case report
Publicado: (2022)

Thrombin: Lack of efficacy: case report
Publicado: (2022)

Tozinameran: Lack of efficacy: case report
Publicado: (2022)

Heparin: Lack of efficacy: case report
Publicado: (2022)

Lorazepam: Lack of efficacy: case report
Publicado: (2022)

Elasomeran: Lack of efficacy: case report
Publicado: (2022)

Ravulizumab: Lack of efficacy: case report
Publicado: (2022)

Paracetamol: Lack of efficacy: case report
Publicado: (2022)

Teriflunomide: Lack of efficacy: case report
Publicado: (2022)

Plasma: Lack of efficacy: case report
Publicado: (2022)

Norepinephrine: Lack of efficacy: case report
Publicado: (2022)

Gammaglobulin: Lack of efficacy: case report
Publicado: (2022)

Antipsoriatics: Lack of efficacy: case report
Publicado: (2022)

Tozinameran: Lack of efficacy: case report
Publicado: (2022)

Heparin: Lack of efficacy: case report
Publicado: (2022)

Insulin: Lack of efficacy: case report
Publicado: (2022)

Methylprednisolone: Lack of efficacy: case report
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1rskfcb0fchcckqet3jkm7fv8s